glp 1 drug companies GLP-1 Market Industry Trends and Global Forecasts 2024-2035: Over 150 GLP-1 Candidates in Development for Multiple Indications, Type 2 Diabetes and Obesity Drive GLP-1 Drug Development Boom Market Overview: GLP-1 Agonists and

Description

Because if protein, supplements, coaching, strength training, CGMs, or nutrition programs can improve GLP-1 outcomes, reduce side effects, or help people maintain results after discontinuation That is not just wellness. That is evidence worth generating

drugs like Ozempic).

Obesity and type 2 diabetes remain critical global health challenges, with rising prevalence demanding innovative treatment approaches

however, they can also lead to nutrient depletion

Future research should focus on longitudinal dietary assessment, biomarker monitoring, and validation of standardized nutrition protocols for patients receiving GLP1-based obesity pharmacotherapy.